Updated Jul 16, 2026
Wheadon David E. has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.
David E. Wheadon is listed as a director of Indivior Pharmaceuticals, Inc. (INDV) in SEC filings, with the most recent filing dated 2026-01-28 showing no purchases or sales by him. The available SEC context provides limited biographical information beyond his role on the board at Indivior Pharmaceuticals, Inc.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | SHC | Sotera Health Co | A — Grant or award | 15.0K | $0.00 | |
| 2026-05-14 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 10.4K | $0.00 | |
| 2026-01-28 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 6.0K | $0.00 |
David E. Wheadon is listed as a director of Indivior Pharmaceuticals, Inc. (INDV) in SEC filings, with the most recent filing dated 2026-01-28 showing no purchases or sales by him. The available SEC context provides limited biographical information beyond his role on the board at Indivior Pharmaceuticals, Inc.…
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wheadon David E. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.